Detalles de la búsqueda
1.
Higher Adalimumab Concentration is Associated with Complete Fistula Healing in Patients with Perianal Fistulizing Crohn's Disease.
Clin Gastroenterol Hepatol
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38692557
2.
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Ther Drug Monit
; 46(3): 291-308, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38648666
3.
Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease.
J Pediatr Gastroenterol Nutr
; 78(2): 261-271, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38374555
4.
Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH Trial.
Am J Gastroenterol
; 118(3): 485-490, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624036
5.
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
Am J Gastroenterol
; 118(11): 2005-2013, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37207314
6.
Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases.
Ther Drug Monit
; 45(5): 579-590, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012629
7.
Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor.
Clin Gastroenterol Hepatol
; 20(2): 465-467.e2, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33421628
8.
Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case Series.
Dig Dis Sci
; 67(1): 252-258, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33595782
9.
Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 19(4): 839-841.e2, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32147594
10.
Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis.
Am J Gastroenterol
; 116(5): 1007-1014, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33929379
11.
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
Am J Gastroenterol
; 116(10): 2014-2025, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34388143
12.
Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection.
Clin Infect Dis
; 71(6): 1472-1478, 2020 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31584632
13.
Therapeutic drug monitoring in patients on biologics: lessons from gastroenterology.
Curr Opin Rheumatol
; 32(4): 371-379, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32412995
14.
How, When, and for Whom Should We Perform Therapeutic Drug Monitoring?
Clin Gastroenterol Hepatol
; 18(6): 1291-1299, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31589978
15.
Patients over Age 75 Are at Increased Risk of Emergency Department Visit and Hospitalization Following Colonoscopy.
Dig Dis Sci
; 65(7): 1964-1970, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31784850
16.
Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies.
Clin Immunol
; 206: 9-14, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29545207
17.
Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's Disease.
Gastroenterology
; 164(1): 164-165, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35436497
18.
Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?
Clin Gastroenterol Hepatol
; 22(1): 200-201, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211267
19.
Risankizumab concentration but not IL-22 levels are associated with clinical and biochemical remission in patients with Crohn's disease.
Clin Gastroenterol Hepatol
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38705437
20.
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 17(9): 1655-1668.e3, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30928454